Featured |
International
Clever Leaves Holdings Inc (NASDAQ: CLVR, CLVRW) ("Clever Leaves"), a global medical cannabis company, today announced the arrival of the first shipment of medical cannabis extracts from Colombia to its Swiss-based partner Astrasana Holding AG ("Astrasana"). This is Clever Leaves' first commercial shipment to Switzerland, where Astrasana is an established distributor of medical cannabis. In addition, Clever Leaves and Astrasana are preparing the first shipment of medicinal cannabis extracts to the Czech Republic, where Astrasana maintains pharmaceutical operations and operates its own dispensary specializing in the sale of medicinal cannabis.
The supply agreement between Clever Leaves and Astrasana will allow Clever Leaves to expand into new European markets and further solidify its position as a global supplier of medical cannabis. Both Switzerland and the Czech Republic have recently seen legislative changes in favor of medical cannabis and are at the forefront of the emerging European cannabis industry.
"The supply agreement guarantees Astrasana a reliable and consistent supply of medicinal cannabis extracts at competitive prices, provides planning certainty and enables smooth operations"
"This partnership with Clever Leaves not only ensures a continued supply of high-quality medical cannabis products to Astrasana's customers, but also intensifies the existing collaboration between the two companies and paves the way for future growth opportunities."
says Yves Antoniazzi, CEO of Astrasana Holding.
Clever Leaves, a publicly traded company with a strong reputation in the cannabis industry, has been operating since 2016 and is known for its expertise in producing high-quality medical cannabis extracts. The company's commitment to maintaining the highest standards in the industry aligns perfectly with Astrasana's values and mission to provide safe and effective medical cannabis products to patients worldwide.
"Clever Leaves' first commercial shipment of medical cannabis extracts to Astrasana in Switzerland is an important step towards our goal of expanding patient access to high-quality medical cannabis throughout Europe and beyond. Through our strategic partnership with Astrasana, we look forward to aligning our capabilities and further penetrating new countries in Europe such as Switzerland and the Czech Republic. As a company, we remain focused on driving innovation in the industry and developing safe, pharmaceutical-grade products for patients in need," said Andres Fajardo, co-founder and CEO of Clever Leaves.
With Clever Leaves' global reach and expertise in the cannabis industry, Astrasana is positioned to further strengthen its position as a leading supplier and distributor of medical cannabis in the Czech Republic and Switzerland.